Is there any relation between rnv transkeltolase activity and thiamine

Reading File

Searching the Web

RBC transketolase activity thiamine deficiency TPP effect

Finding Sources

Reading File

Here is a thorough answer based on authoritative textbook sources:

RBC (Erythrocyte) Transketolase Activity and Thiamine - The Relationship

The Biochemical Link

Thiamine (vitamin B1) is converted in the body to its active coenzyme form, thiamine pyrophosphate (TPP), by transfer of a pyrophosphate group from ATP. TPP is an essential cofactor for transketolase, an enzyme that catalyzes two key reactions in the pentose phosphate pathway (also called the hexose monophosphate shunt).

Transketolase exists in two forms:

Holoenzyme - the active form with TPP bound
Apoenzyme - the inactive form lacking TPP

When thiamine is adequate, most transketolase exists as holoenzyme. As thiamine becomes deficient, TPP is depleted, the apoenzyme fraction increases, and overall transketolase activity falls.

Biochemistry, 8th ed Lippincott Illustrated Reviews, p. 1064

Why RBCs Specifically?

Red blood cells are the preferred sample because:

They lack mitochondria, so they do not contain mitochondrial TPP-dependent enzymes (like pyruvate dehydrogenase) that could confound results
RBCs do contain the cytosolic TPP-requiring transketolase
Transketolase within erythrocytes is independent of non-specific changes in extracellular plasma

Biochemistry, 8th ed Lippincott Illustrated Reviews, p. 456
Tietz Textbook of Laboratory Medicine, 7th Ed, p. 1285

The TPP Effect - The Diagnostic Test

The functional assay works by measuring transketolase activity before and after adding exogenous TPP to the erythrocyte hemolysate in vitro:

Measurement	Meaning
Basal (without TPP)	Holoenzyme activity = reflects current thiamine status
After TPP addition	Total potential activity (holo + apo)
% increase = "TPP effect"	Degree of thiamine depletion

Interpretation of the % TPP effect (activation coefficient):

< 15% - Normal thiamine status (ETKAC < 1.15)
15-25% - Moderate risk / insufficiency (ETKAC 1.15-1.25)
> 25% - Thiamine deficiency (ETKAC > 1.25)

A large % increase after adding TPP means a lot of apoenzyme was sitting inactive - indicating that thiamine had been the limiting factor, i.e., the patient is thiamine deficient.

Tietz Textbook of Laboratory Medicine, 7th Ed, p. 1285-1286

Clinical Significance

In Wernicke's encephalopathy (a severe thiamine deficiency state seen in chronic alcoholism), patients show a marked reduction in functional transketolase activity before treatment. After IV thiamine administration, transketolase activity normalizes within hours. This is exploited diagnostically - Adams and Victor's Principles of Neurology notes this is a reliable pre-treatment marker.

The test also detects subclinical deficiency before clinical signs (beriberi, Wernicke-Korsakoff syndrome) appear.

Limitations of the Assay

The Tietz textbook also flags important caveats:

Limitation	Detail
Apoenzyme depletion may be non-nutritional	Liver disease, diabetes can affect enzyme levels independently
Genetic variants	Abnormal TPP binding unrelated to dietary thiamine
Cofactor influence	Magnesium deficiency can lower transketolase activity
Standardization issues	Less robust than direct HPLC measurement of erythrocyte thiamine pyrophosphate

For this reason, direct measurement of erythrocyte thiamine pyrophosphate by HPLC is now considered more precise and robust by some authorities, though the transketolase activation test remains widely used due to its large historical database.

Summary

The relationship is direct and fundamental: transketolase requires TPP (active thiamine) to function. RBC transketolase activity is therefore a functional biomarker of whole-body thiamine status. The "TPP effect" quantifies this dependency and is the basis for diagnosing thiamine deficiency clinically. A TPP effect of >25% is the classic threshold for diagnosing deficiency.

This is a shared conversation. Sign in to Orris to start your own chat.